Hayes, Inc. to Present on Genetic Testing at 33rd Annual ROSE Conference

Share Article

Renee Balliet, PhD, MBA, will speak to attendees about how to discern fact from hype in the field of genetic testing.

Renee Balliet

Renee Balliet

Our presentation at the ROSE Conference will provide attendees with some of the guidance they need to navigate the volume and complexity of genetic testing.

The Reinsurance Group of America, Inc. (RGA) will hold their 33rd annual ROSE Conference in September. This year, Dr. Balliet will represent Hayes, Inc. with the presentation “Navigating the Hype of Genetic Testing” on September 14, 2017, at 11:00 AM to 12:15 PM CDT. Dr. Balliet will present how payers can sift through the maze of genetic tests to enhance management and claim outcomes.

“I’m honored to represent Hayes by speaking about such an important topic in healthcare today,” says Dr. Balliet. “The volume of commercially available genetic tests alone presents a significant challenge to payers when determining their coverage policies. Our presentation at the ROSE Conference will provide attendees with some of the guidance they need to navigate the volume and complexity of genetic testing.”

In her presentation, Dr. Balliet will address the following objectives:

  •     Understanding the current regulatory landscape
  •     Identifying key criteria when assessing tests that look at somatic variants
  •     Understanding germline genetic testing and why standard definitions of clinical utility may not be appropriate
  •     Exploring the future of molecular diagnostics

Renee Balliet, PhD, MBA, is the Product Manager for the Hayes Genetic Test Evaluation (GTE) program. She is responsible for the topic selection, development, and scientific review of GTE reports at Hayes. Additionally, she has authored and co-authored numerous papers in the fields of pharmacogenetics and tumor etiology. The Hayes GTE program provides the fiercely unbiased, evidence-based reports payers need to make defensible coverage decisions. Payers use the GTE program to develop coverage policy for genetic testing and to make coverage determination in the absence of policy.

Each year, the ROSE Conference welcomes nurses, case managers, claim specialists, claim managers, physicians, and others who work in group disability or health insurance across the U.S. and Canada. Attendees receive pragmatic and insightful information to enhance case management, claim outcomes, and customer service for their policy holders and claimants. The ROSE Conference will be held on September 13 to 15, 2017, at the Hotel Minneapolis in Minneapolis, MN. Online registration is open now.

Hayes, Inc., an internationally recognized leader in health technology research and consulting, is dedicated to the delivery of high-quality healthcare and improved outcomes through the integration of evidence into decision making and policy development. The unbiased information and comparative-effectiveness analyses we provide enable evidence-based decisions about acquiring, managing, and paying for health technologies. Our worldwide clients include hospitals, healthcare systems, government agencies, health plans, and employers. For more information about Hayes, Inc., visit http://www.hayesinc.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Jim Hollis
Hayes, Inc.
215.855.0615 Ext: 4744
Email >
Follow us on
Visit website